Antineoplastic agents 300. Isolation and structure of the rare human cancer inhibitory macrocyclic lactones spongistatins 8 and 9

Journal of the Chemical Society, Chemical Communications

Volumn , Issue 13, 1994, Pages 1605-1606

  Pettit, George R ^a   Cichacz, Zbigniew A ^a   Herald, Cherry L ^a   Gao, Feng ^a   Boyd, Michael R ^b   Schmidt, Jean M ^a   Hamel, Ernest ^c   Bai, Ruoli ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID; MACROLIDE; SPONGISTATIN 8; SPONGISTATIN 9; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CHEMICAL STRUCTURE; DRUG ISOLATION; DRUG POTENCY; MICROTUBULE ASSEMBLY; SPONGE;

EID: 0028279351     PISSN: 00224936     EISSN: None     Source Type: Journal    
DOI: 10.1039/C39940001605     Document Type: Article

References (23)

1. C. Stanwell, A. Gescher, T. D. Bradshaw and G. R. Pettit, Int. J. Cancer, 1994, 56, 585.
2. G. R. Pettit, J. F. Day, J. L. Hartwell and H. B. Wood, Nature, 1970, 227, 962.
3. G. R. Pettit, Z. A. Cichacz, F. Gao, C. L. Herald, M. R. Boyd, J. M. Schmidt and J. N. A. Hooper, J. Org. Chem., 1993, 58, 1302.
4. G. R. Pettit, R. Tan, F. Gao, M. D. Williams, D. L. Doubek, M. R. Boyd, J. M. Schmidt, J-C. Chapuis, E. Hamel, R. Bai, J. N. A. Hooper and L. P. Tackett, J. Org. Chem., 1993, 58, 2538.
5. D. C. Radisky, E. S. Radisky, L. R. Barrows, B. R. Copp, R. A. Kramer and C. M. Ireland, J. Am. Chem. Soc., 1993, 115, 1632.
6. S. Kanazawa, N. Fusetani and S. Matsunaga, Tetrahedron Lett., 1993, 34, 1065.
7. J. Kobayashi, M. Tsuda, T. Nakamura, Y. Mikami and H. Shigemori, Tetrahedron, 1993, 49, 2391.
8. G. R. Pettit, J. K. Srirangam, D. L. Herald, K. L. Erickson, D. L. Doubek, J. M. Schmidt, L. P. Tackett and G. J. Bakus, J. Org. Chem., 1992, 57, 7217.
9. M. Chbani, M. Païs, J.-M. Delauneux and C. Debitus, J. Nat. Prod., 1993, 56, 99.
10. A. D. Rodriguez and O. M. Cóbar, Tetrahedron, 1993, 49, 319.
11. A. Casapullo, E. Finamore, L. Minale, F. Zollo, J. B. Carré, C. Debitus, D. Laurent, A. Folgore and F. Galdiero, J. Nat. Prod, 1993, 56, 105.
12. G. R. Pettit, Z. A. Cichacz, F. Gao, C. L. Herald, M. R. Boyd, J. M. Schmidt and J. N. A. Hooper, J. Org. Chem., 1993, 58, 1302.
13. G. R. Pettit, Z. A. Cichacz, F. Gao, C. L. Herald and M. R. Boyd, J. Chem. Soc., Chem. Commun., 1993, 1166.
14. G. R. Pettit, C. L. Herald, Z. A. Cichacz, F. Gao, J. M. Schmidt, M. R. Boyd, N. D. Christie and Fred E. Boettner, J. Chem. Soc., Chem. Commun., 1993, 1805.
15. G. R. Pettit, C. L. Herald, Z. A. Cichacz, F. Gao, M. R. Boyd, N. D. Christie and J. M. Schmidt, Nat. Prod. Lett., 1993, 3, 239.
16. M. Kobayashi, H. Uehara, K. Matsunami, S. Aoki and I. Kitagawa, Tetrahedron Lett., 1993, 34, 7925.
17. N. Fusetani, K. Shinoda and S. Matsunago, J. Am. Chem. Soc., 1993, 115, 3977.
18. M. R. Boyd, Status of the NCl preclinical antitumor drug discovery screen, in Principles and Practices of Oncology Updates, ed. V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg, Lippincott, Philadelphia, 1989, vol. 10, No. 3, pp. 1–12.
19. M. R. Boyd, K. D. Paull and L. R. Rubinstein, Data display and analysis strategies from NCl disease-oriented in vitro antitumor drug screen, in Cytotoxic Anticancer Drug Models and Concepts for Drug Discovery and Development, ed. F. A. Valeriote, T. Corbett and L. Baker, Kluwer Academic Publishers, Amsterdam, 1992, pp. 11–34.
20. M. R. Boyd, The Future of New Drug Development, in Current Therapy in Oncology, ed. J. E. Niederhuber, Mosby Publishing, St. Louis, 1993, pp. 11–22.
21. E. Hamel, Interaction of Tubulin with Small Ligands, in Microtubule Proteins, ed. J. Avila, CRC Press, Boca Raton, FL., 1990, pp. 89–191.
22. R. Bai, G. R. Pettit and E. Hamel, Biochem. Pharmacol., 1990, 39, 1941.
23. R. Bai, Z. A. Cichacz, C. L. Herald, G. R. Pettit and E. Hamel, Mol. Pharmacol., 1993, 44, 757.